Cited by 636Gastrointestinal motility and disordersStress Responses and CortisolInflammatory Bowel Disease

Hypothalamic-Pituitary-Gut Axis Dysregulation in Irritable Bowel Syndrome: Plasma Cytokines as a Potential Biomarker?

Open access
Dinan, Timothy G., Quigley, Eamonn M.M., Ahmed, Salah M.M., Scully, Paul, O’Brien, Sinead, O’Mahony, Liam, O’Mahony, Siobhan, Shanahan, Fergus +1 more·2006·Gastroenterology

Abstract

Background & aims Irritable bowel syndrome (IBS) is a functional disorder with an etiology that has been linked to both psychological stress and infection. The primary aim of this study was to examine the hypothalamic-pituitary-adrenal axis in patients with IBS and to relate such response to plasma cytokine profiles.Methods A total of 151 subjects, 76 patients and 75 controls, were recruited. The patients with IBS were diagnosed according to Rome II criteria. Forty-nine patients and 48 matched controls had cytokine levels measured, and a subset of 21 patients and 21 controls also underwent a corticotropin-releasing hormone (CRH) stimulation test with plasma levels of adrenocorticotropic hormone (ACTH) and cortisol measured. The remaining 27 patients and 27 controls underwent a dexamethasone (1 mg) challenge.Results Cortisol and the proinflammatory cytokines interleukin (IL)-6 (together with its soluble receptor) and IL-8 were elevated in all IBS subgroups (diarrhea predominant, constipated, and alternators), although the elevation was most marked in the constipated subgroup. There was no alteration in the anti-inflammatory cytokine IL-10. Following CRH infusion, an exaggerated release of both ACTH and cortisol was observed in patients with IBS. There was a significant correlation between the ACTH response (deltaACTH) and the IL-6 levels. A similar relationship existed between the deltaACTH/deltacortisol ratio and the IL-6 levels. Dexamethasone suppression of cortisol was similar in patients and controls.Conclusions IBS is characterized by an overactivation of the hypothalamic-pituitary-adrenal axis and a proinflammatory cytokine increase.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2005.11.033

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients with irritable bowel syndrome had exaggerated ACTH and cortisol responses to CRF infusion together with an altered microbiota.

    “In humans, patients with irritable bowel syndrome had exaggerated ACTH and cortisol responses to CRF infusion (Dinan et al., 2006) together with an altered microbiota (Eisenstein, 2016;Grenham et al., 2011).”

    From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Dinan et al., 2006

  • Higher concentrations of TNFa, IL-6, IL-8 and IL-12 in blood plasma or PBMCs have been linked to IBS.

    “Elevated levels of tumour necrosis factor (TNF)a , interleukin (IL)-6, IL-8 and IL-12 in plasma or peripheral blood mononuclear cells (PBMCs) have been connected to IBS. 2, 19, 20”
  • Inflammation is present in IBS, as indicated by studies on mast cells and cytokines.

    “Studies on mast cells and cytokines point out that inflammation is present in IBS. 2, 13-20”
  • Patients with IBS have increased concentrations of inflammatory/immune cells in intestinal tissue compared with controls.

    “Evidence supporting this hypothesis includes increased concentrations of inflammatory/immune cells in intestinal tissue from IBS patients, altered levels of pro- and anti-inflammatory cytokines in the GI tract and peripheral blood of patients with IBS (Table 1) (11, 13, 24, 36, 46, 50, 51, 62, 73, 75, 89, 90, 94, 98, 102, 118, 121–124, 168, 174, 185, 187), and IBS-associated polymorphisms in genes”
  • Patients with IBS have altered levels of pro- and anti-inflammatory cytokines in the GI tract and peripheral blood compared with controls.

    “Evidence supporting this hypothesis includes increased concentrations of inflammatory/immune cells in intestinal tissue from IBS patients, altered levels of pro- and anti-inflammatory cytokines in the GI tract and peripheral blood of patients with IBS (Table 1) (11, 13, 24, 36, 46, 50, 51, 62, 73, 75, 89, 90, 94, 98, 102, 118, 121–124, 168, 174, 185, 187), and IBS-associated polymorphisms in genes”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Dunn AJ. Systemic interleukin-1 administration stimulates hypo- thalamic norepinephrine metabolism paralleling the increased plasma corticosterone. Life Sci 1988;43:429 -435.
  2. Pollmacher T, Haack M, Schuld A, Reichberg A, Yirmiya R. Low levels of circulating inflammatory cytokines-do they affect brain functions. Brain Behav Immun 2002;16:525-532.
  3. Scott LV, Dinan TG. The role of vasopressin in the regulation of the hypothalamic-pituitary-adrenal axis. Life Sci 1997;62:1985- 1998.
  4. Rubin RT, Dinan TG, Scott LV. The neuroendocrinology of affec- tive disorders. In: Pfaff D, Arnold AP, Etgen AM, Faahrbach SE, Moss RL, Rubin RT (eds). Hormones, brain and behaviour. New York, NY: Academic Press, 2001.

Cited by

Sorted by citations

Authors
Dinan, T. G., Quigley, E. M. M., Ahmed, S. M. M., Scully, P., O’Brien, S., O’Mahony, L., O’Mahony, S., Shanahan, F., & Keeling, P. W. N.
Affiliations
  • University College Cork (IE)
  • Trinity College Dublin (IE)
Corresponding author
Dinan, Timothy G.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2006-02
Volume
130
Issue
2
Pages
304-311
ISSN
0016-5085 (ISSN-L)
OpenAlex
W1976118863
Cited by
636
References
52
Citations by year
2026: 19 · 2025: 13 · 2024: 21 · 2023: 22 · 2022: 21 · 2021: 35 · 2020: 28 · 2019: 27 · 2018: 26 · 2017: 34 · 2016: 37 · 2015: 38 · 2014: 33 · 2013: 38 · 2012: 44
FWCI
39.51
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Health Research Board
  • Science Foundation Ireland
  • Wellcome Trust
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
Keywords
irritable bowel syndrome, hypothalamic-pituitary-adrenal axis, plasma cytokines, interleukin-6, interleukin-8, IL-10, cortisol, ACTH, corticotropin-releasing hormone stimulation test, dexamethasone suppression test, inflammatory cytokines, irritable bowel syndrome with constipation, diarrhea-predominant irritable bowel syndrome, biomarkers
MeSH terms
Adrenocorticotropic Hormone, Adult, Alcohol Drinking, Dexamethasone, Female, Humans, Hypothalamo-Hypophyseal System, Intestines, Ireland, Male, Pain, Reference Values, Biomarkers, Interleukin-6, Cytokines, Interleukin-8, Interleukin-10, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review